RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
2025 Market Outlook: Key January Events to Watch 
UBS Projects Mixed Market Outlook for 2025 Amid Trump Policy Uncertainty 
China’s Growth Faces Structural Challenges Amid Doubts Over Data 
European Stocks Rally on Chinese Growth and Mining Merger Speculation 
Will a new border deal with the US open a backdoor into Kiwis’ personal data? 
Goldman Predicts 50% Odds of 10% U.S. Tariff on Copper by Q1 Close 
U.S. Treasury Yields Expected to Decline Amid Cooling Economic Pressures 
How will the Iran war change the Middle East? We asked 5 experts 
Lithium Market Poised for Recovery Amid Supply Cuts and Rising Demand 
Indonesia Surprises Markets with Interest Rate Cut Amid Currency Pressure 
U.S. Banks Report Strong Q4 Profits Amid Investment Banking Surge 
U.S. Stocks vs. Bonds: Are Diverging Valuations Signaling a Shift? 
Gamma ownership in EUR and USD against EMFX space is rendering lucrative options on central bank meetings (c.f. BoE), and in vega-neutral steepener format along steep vol curves.
EURNZD gamma is still good value on RBNZ’s status; +2M/-6M calendars in EURTRY and USDMXN screen cheap.
EURNZD is the NZD-cross that screens the best value in gamma to benefit from such a turn of events (refer above chart; 2W ATM 8.1 vs. hourly realized vol 1-wk 9.0, 4-wk 9.5) and is worth holding into the event.
Directional plays for a tactical NZD bounce could take the form of either 1M 1.64 EUR put/NZD call one touch (5X gearing off spot ref. 1.6815) or 1M 1.671.65 put spread (3.5X).
High carry and chronic risk-reversal underperformance suggest value in at-expiry digital risk-reversals in EURRUB to benefit from higher oil prices.
Carry/vol ratios in long-dated TRY options are testing 2008’s record highs.
Liquidity permitting, long-dated EURTRY straddles are worth owning against a bullish EM portfolio.
